Results 291 to 300 of about 305,759 (329)
Some of the next articles are maybe not open access.
Complement and Complement Regulatory Proteins in Diabetes
2015In this chapter we have summarized the body of evidence that supports a role for the complement system and complement regulatory proteins in the pathogenesis of diabetic complications, with specific emphasis on the novel phenomenon of glycation-inactivation of CD59.
Jose A. Halperin +3 more
openaire +1 more source
Molecular remodeling of complement regulatory proteins for xenotransplantation
Immunopharmacology, 1999In pig-to-human discordant xenotransplantation, human complement is a major barrier against long survival of xenografts. Human complement regulatory proteins expressed on xenografts have been adapted as safeguards against host-induced hyperacute rejection of xenografts.
T, Seya +5 more
openaire +2 more sources
Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Current Pharmaceutical Design, 2004By-products of complement activation and complement regulatory proteins are increasingly recognized to play an important pathogenic role in a variety of vascular diseases including atherosclerosis, ischemia and reperfusion injury, hyperacute graft rejection, vasculitis, and the vascular complications of human diabetes.
Juan, Acosta +2 more
openaire +2 more sources
Complement Regulatory Proteins and Autoimmunity
2001To discriminate self from non-self is an essential issue in the immune system. Autologous cells are protected against complement-mediated cell injury by the self-recognition mechanism using complement regulatory proteins composed of complement receptor type 1 (CR1, CD35), membrane cofactor protein (MCP, CD46), decay accelerating factor (DAF, CD55) and ...
openaire +2 more sources
C4b-Binding protein, a regulatory protein of complement
Immunologic Research, 1991Despite the wealth of structural and functional information on C4BP, it is clear that several aspects of C4BP biology and regulation under normal conditions and in the acute-phase response remain unresolved. Studies to identify which interleukin and cytokines regulate C4BP expression (both α-and β-chains) are underway in our laboratory.
openaire +2 more sources
European Journal of Cardio-Thoracic Surgery, 1993
Cardiopulmonary bypass-induced organ dysfunction remains a clinical problem in certain groups of patients. Although the pathogenesis is multifactorial, it is likely that a panendothelial injury consequent upon widespread humoral and cellular activation is a major contributor to this process. The biologically active products of complement activation are
N E, Moat, D F, Shore, T W, Evans
openaire +2 more sources
Cardiopulmonary bypass-induced organ dysfunction remains a clinical problem in certain groups of patients. Although the pathogenesis is multifactorial, it is likely that a panendothelial injury consequent upon widespread humoral and cellular activation is a major contributor to this process. The biologically active products of complement activation are
N E, Moat, D F, Shore, T W, Evans
openaire +2 more sources
Structure-Function Relationships of the Complement Regulatory Protein, CD59
Blood Cells, Molecules, and Diseases, 1996CD59 (membrane inhibitor of reactive lysis, protectin) is a membrane protein whose functions include the inhibition of the insertion of the ninth component of complement into the target membrane. It belongs to a superfamily of proteins including Ly-6, elapid snake venom toxins, and urokinase receptor (UPAR); the members of the superfamily have a ...
J, Petranka +6 more
openaire +2 more sources
Exploitation of complement regulatory proteins by Borrelia and Francisella
Molecular BioSystems, 2015BorreliaandFrancisellainteract differently with complement regulatory proteins from various hosts, which influences the disease development and ecology of pathogens.
Marian, Madar +9 more
openaire +2 more sources
Effect of hybrid complement regulatory proteins on xenogeneic cells
Biochemical and Biophysical Research Communications, 2003To suppress C3 fragment deposition in the classical pathway complement activation on xenogeneic membranes, decay accelerating factor (DAF) was the most effective molecule among the complement regulatory proteins (CRPs) used in the present study. C3 fragment deposition was closely related to subsequent xenogeneic cell lysis.
Daisuke, Fukuta +6 more
openaire +2 more sources
Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis
Lupus, 2000This study assessed the expression of complement receptor 1 (CR1), decay accelerating factor (DAF) and membrane inhibitor of reactive lysis (CD59) on the erythrocytes and glomerulus of diffuse proliferative glomerulonephritis (DPGN) of systemic lupus erythematosus (SLE) patients using flow cytometry and immunofluorescence techniques to elucidate their
M, Arora +4 more
openaire +2 more sources